About Zoetis Inc.
Zoetis Inc. (ZTS) has been publicly traded since 2013, making it a 13-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Parsippany, United States and employs approximately 14,500 people. With a market capitalization of $51 billion, ZTS is a large established company.
Key Statistics
- Current Price
- $115.54
- Market Cap
- $50.92B
- 52-Week High
- $172.23
- 52-Week Low
- $114.47
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -7.78% | $125.29 | $115.54 |
| 2025 | -21.75% | $160.11 | $125.29 |
| 2024 | -16.63% | $192.05 | $160.11 |
| 2023 | +35.91% | $141.31 | $192.05 |
| 2022 | -39.51% | $233.59 | $141.31 |
| 2021 | +48.26% | $157.55 | $233.59 |
| 2020 | +25.76% | $125.28 | $157.55 |
| 2019 | +55.71% | $80.46 | $125.28 |
| 2018 | +19.45% | $67.36 | $80.46 |
| 2017 | +35.55% | $49.69 | $67.36 |
| 2016 | +12.64% | $44.11 | $49.69 |
| 2015 | +12.18% | $39.33 | $44.11 |
| 2014 | +32.80% | $29.61 | $39.33 |
Valuation
ZTS currently trades at a trailing P/E ratio of 19.2, which is considered moderate relative to the broader market. The forward P/E of 15.3 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 14.7. The price-to-sales ratio is 5.4.
Dividends
Zoetis Inc. pays a dividend to shareholders with a current yield of 1.83%. This translates to $2.12 per share annually. The payout ratio of 33% indicates sustainable dividend coverage.
Risk & Volatility
ZTS has a beta of 0.95, indicating it is similarly volatile to the overall market. The stock's 52-week range is $114.47 to $172.23, and it currently trades near its 52-week low.
Analyst Ratings
Based on 16 analyst opinions, ZTS has a consensus "buy" rating. The average price target of $151.00 suggests 30.6% upside from current levels.
Frequently Asked Questions
What does Zoetis Inc. do? ▼
Zoetis Inc. is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Parsippany, United States.
What sector is ZTS in? ▼
ZTS operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did ZTS go public? ▼
Zoetis Inc. went public in 2013, making it a 13-year-old public company as of 2026.
How much would $1,000 invested in ZTS 5 years ago be worth today? ▼
A $1,000 investment in ZTS five years ago would be worth approximately $807 today, representing a -19.3% return.
Does ZTS pay dividends? ▼
Yes, Zoetis Inc. pays a dividend with a current yield of 1.83%, which is $2.12 per share annually.
What is ZTS's market cap? ▼
Zoetis Inc. has a market capitalization of $51 billion, classifying it as a large-cap company.
What is ZTS's P/E ratio? ▼
ZTS has a trailing P/E ratio of 19.2 and a forward P/E of 15.3, which measures how much investors are paying per dollar of earnings.
Is ZTS a buy, hold, or sell? ▼
Based on 16 opinions, ZTS has a consensus "buy" rating. The average price target is $151.0.
Last updated: 3/14/2026